External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma - A prospective randomized study

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages 1249-1255

  Sorbe, Bengt ^a   Horvath, György ^b   Andersson, Hkan ^b   Boman, Karin ^c   Lundgren, Caroline ^d   Pettersson, Birgitta ^e  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

Endometrial cancer; Locoregional tumor control; Medium risk group; Postoperative radiotherapy; Prognostic factors; Randomized trial

Indexed keywords

DISEASES; IRRADIATION; TOXICITY; TUMORS;

ENDOMETRIAL CANCER; POSTOPERATIVE RADIOTHERAPY; PROGNOSTIC FACTORS; RANDOMIZED TRIAL; RISK GROUPS; TUMOR CONTROL;

RADIOTHERAPY;

ADULT; AGED; CANCER CONTROL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MYOMETRIUM; OVERALL SURVIVAL; PELVIS; PLOIDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE FREE INTERVAL; RECURRENCE FREE SURVIVAL; REVIEW; RISK FACTOR; TOXICITY; VAGINA;

EID: 84856376656     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.04.014     Document Type: Article

References (23)

1. J. Aalders, V. Abeler, and P. Kolstad Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients Obstet Gynecol 56 1980 419 427
2. C.L. Creutzberg, W.L. van Putten, and P.C. Koper Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma Lancet 355 2000 1404 1411
3. H.M. Keys, J.A. Roberts, and V.L. Brunetto A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecol Oncol Group study Gynecol Oncol 92 2004 744 751
4. P. Blake, A.M. Swart, J. Orton ASTEC/EN.5 Study Group Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and metaanalysis Lancet 373 2009 137 146
5. R.A. Nout, V.T. Smit, and H. Putter Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
6. R.A. Nout, H. Putter, and I.M. Jurgenliemk-Schulz Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: First results of the randomized PORTEC-2 trial J Clin Oncol 27 2009 3547 3556
7. T. Högberg, M. Signorelli, and C.F. de Oliveira Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - Results from two randomized studies Eur J Cancer 36 2 2010 371 378
8. J.H. Shepherd Revised FIGO staging for gynaecological cancer Br J Obstet Gynaecol 96 1989 889 892
9. D. Gal, O.F. Recio, and D. Zamurovic The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma Cancer 69 1992 200 202
10. H.K. Poulsen, M. Jacobsen, and K. Bertelsen Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk cases Int J Gynecol Cancer 6 1996 38 43
11. A. Obermaier, R. Cheuk, and S.C. Pak Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma Gynecol Oncol 110 2008 280 285
12. B. Sorbe, B. Nordström, and J. Mäenpää Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: A controlled randomized study Int J Gynecol Cancer 19 2009 873 878
13. C.L. Creutzberg, W.L. van Putten, and P.C. Koper Survival after relapse in patients with endometrial cancer: Results from a randomized trial Gynecol Oncol 89 2003 201 209
14. J.C. Schink, A.W. Rademaker, and D.S. Miller Tumor size in endometrial cancer Cancer 67 1991 2791 2794
15. D.E. Cohn, N.S. Horowitz, and D.G. Mutch Should the presence of lymph vascular space involvement be use to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 87 2002 243 246
16. V.J. Kumar, C.Y. Nin, and L.Y. Kuei Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy Int J Gynecol Cancer 20 2010 564 569
17. C.L. Creutzberg, W.L. van Putten, and P.C. Koper The morbidity of treatment for patients with Stage I endometrial cancer: Results from a randomized trial Int J Radiat Oncol Biol Phys 51 2001 1246 1255
18. C.L. Creutzberg, W.L. van Putten, and C.C. Warlam-Rodenhuis Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: The Postoperative Radiation Therapy in Endometrial Carcinoma trial J Clin Oncol 22 2004 1234 1241
19. A.J. Mundt, R. McBride, and J. Rotmensch Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy Int J Radiat Oncol Biol Phys 50 2001 1145 1153
20. P.P. Benedetti, S. Basile, and F. Maneschi Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial J Natl Cancer Inst 100 2008 1707 1716
21. H. Kitchener, A.M. Swart, Q. Qian ASTEC study group Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomized study Lancet 373 2009 125 136
22. A. Mariani, S.C. Dowdy, and W.A. Cliby Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging Gynecol Oncol 109 2008 11 18
23. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346